In Brief: ChemTrak
This article was originally published in The Gray Sheet
ChemTrak: Will "redraft and resubmit" a 510(k) submission for its quantitative Theophylline test -- used to measure blood levels of the drug in asthma patients for proper dosage titration -- following an FDA request for additional information on the original filing. The Sunnyvale, California firm made the decision after determining it could not make FDA's 30-day response deadline...
You may also be interested in...
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.